Analyze Diet
Biomolecules2025; 15(10); 1444; doi: 10.3390/biom15101444

Glycan Signatures on Neutrophils in an Equine Model for Autoimmune Uveitis.

Abstract: Glycosylation of surface proteins is a crucial post-translational modification that reflects the activation status of neutrophils, the predominant leukocyte subset in humans and horses. Neutrophils have emerged as active contributors to diseases mediated by the adaptive immune system, such as equine recurrent uveitis (ERU), a sight-threatening disease in horses and a unique model for studying the pathogenesis of autoimmune uveitis in humans. Since changes in surface glycosylation can impact neutrophil function, we were interested in the surface glycosylation landscape on neutrophils from healthy horses and the potential changes in surface glyco-signatures in ERU. Using 35 different plant lectins, we outlined a profile of surface-exposed glycan moieties on equine neutrophils and detected significantly increased O-glycosylation in a diseased state through Jacalin (JAC) binding via flow cytometry. Subsequent molecular weight comparison of JAC pull-down assay data and neutrophil proteomics indicated the surface proteins Integrin beta-2 and CUB domain-containing protein 1 as potential anchors for increased O-glycan levels in ERU. These findings give novel insights into neutrophil surface glycosylation in health and disease and propose O-glycosylation as a possible biomarker for autoimmune uveitis.
Publication Date: 2025-10-12 PubMed ID: 41154673PubMed Central: PMC12562876DOI: 10.3390/biom15101444Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Overview

  • This study investigates changes in sugar molecule patterns (glycosylation) on the surface of neutrophils, a type of white blood cell, in healthy horses compared to those with equine recurrent uveitis (ERU), an autoimmune eye disease.
  • The research identifies increased O-glycosylation on neutrophils in horses with ERU and proposes it as a potential biomarker for autoimmune uveitis.

Introduction to Key Concepts

  • Neutrophils: These are the most abundant leukocytes (white blood cells) in both humans and horses, playing a crucial role in immune defense.
  • Glycosylation: A biochemical process where sugar molecules (glycans) are attached to proteins, affecting protein function and cell communication. Surface protein glycosylation on neutrophils reflects their activation and functional states.
  • Equine Recurrent Uveitis (ERU): A chronic autoimmune eye disease in horses causing repeated inflammation, leading to vision loss. ERU serves as a natural model to understand autoimmune uveitis in humans.

Research Purpose

  • To characterize the pattern of surface-exposed glycans on equine neutrophils in healthy versus ERU-affected horses.
  • To determine if changes in glycosylation, especially O-glycosylation, correlate with disease state, potentially serving as biomarkers or providing insight into disease mechanisms.

Methods

  • Lectin Profiling: The study used 35 different plant lectins, which are proteins that specifically bind to particular glycan structures, to analyze surface glycan patterns on neutrophils by flow cytometry.
  • Jacalin (JAC) Binding Detection: Jacalin is a lectin that binds specifically to O-glycosylated structures. Increased binding to neutrophils suggested higher O-glycosylation in ERU.
  • Protein Identification: Proteins associated with increased O-glycans were identified through a pull-down assay using Jacalin followed by molecular weight comparison and proteomic analysis.

Key Findings

  • Neutrophils from healthy horses exhibit a specific profile of surface glycans detectable by lectin binding.
  • In horses with ERU, there was a significant increase in O-glycosylation on the neutrophil surface, as indicated by enhanced Jacalin binding.
  • Two surface proteins, Integrin beta-2 and CUB domain-containing protein 1, were identified as likely carriers (anchors) of these increased O-glycans in ERU neutrophils.

Implications of the Study

  • The modification of neutrophil surface proteins by O-glycans may influence neutrophil functions such as adhesion, migration, or inflammation during autoimmune uveitis.
  • O-glycosylation changes on neutrophils can potentially serve as biomarkers for early detection or disease monitoring in autoimmune uveitis.
  • Understanding glycosylation patterns in this equine model may provide insights applicable to human autoimmune uveitis, given the similarities in disease mechanisms.

Conclusion

  • This study provides novel information on the glycosylation landscape of neutrophils in health and autoimmune disease, highlighting increased O-glycosylation as a distinguishing feature in ERU.
  • Future research could explore how these glycosylation changes affect neutrophil behavior and contribute to disease progression, as well as validate O-glycosylation as a clinical biomarker.

Cite This Article

APA
Sprenzel CJ, Amann B, Deeg CA, Degroote RL. (2025). Glycan Signatures on Neutrophils in an Equine Model for Autoimmune Uveitis. Biomolecules, 15(10), 1444. https://doi.org/10.3390/biom15101444

Publication

ISSN: 2218-273X
NlmUniqueID: 101596414
Country: Switzerland
Language: English
Volume: 15
Issue: 10
PII: 1444

Researcher Affiliations

Sprenzel, Carolin J
  • Chair of Physiology, Department of Veterinary Sciences, Ludwig-Maximilians-University Munich, D-82152 Martinsried, Germany.
Amann, Barbara
  • Chair of Physiology, Department of Veterinary Sciences, Ludwig-Maximilians-University Munich, D-82152 Martinsried, Germany.
Deeg, Cornelia A
  • Chair of Physiology, Department of Veterinary Sciences, Ludwig-Maximilians-University Munich, D-82152 Martinsried, Germany.
Degroote, Roxane L
  • Chair of Physiology, Department of Veterinary Sciences, Ludwig-Maximilians-University Munich, D-82152 Martinsried, Germany.

MeSH Terms

  • Animals
  • Neutrophils / metabolism
  • Horses
  • Uveitis / metabolism
  • Uveitis / veterinary
  • Uveitis / immunology
  • Uveitis / pathology
  • Polysaccharides / metabolism
  • Autoimmune Diseases / metabolism
  • Autoimmune Diseases / veterinary
  • Autoimmune Diseases / immunology
  • Glycosylation
  • Disease Models, Animal
  • Horse Diseases / metabolism
  • Horse Diseases / immunology

Grant Funding

  • DFG DE 719/4-4 (to C.A.D) / Deutsche Forschungsgemeinschaft

Conflict of Interest Statement

The authors declare no conflicts of interest.

References

This article includes 70 references
  1. de Haan N, Pucic-Bakovic M, Novokmet M, Falck D, Lageveen-Kammeijer G, Razdorov G, Vuckovic F, Trbojevic-Akmacic I, Gornik O, Hanic M. Developments and perspectives in high-throughput protein glycomics: Enabling the analysis of thousands of samples.. Glycobiology 2022;32:651–663.
    doi: 10.1093/glycob/cwac026pmc: PMC9280525pubmed: 35452121google scholar: lookup
  2. He M, Zhou X, Wang X. Glycosylation: Mechanisms, biological functions and clinical implications.. Signal Transduct. Target. Ther. 2024;9:194.
    doi: 10.1038/s41392-024-01886-1pmc: PMC11298558pubmed: 39098853google scholar: lookup
  3. Marrero Roche D.E., Chandler K.B.. Clinical glycoprotein mass spectrometry: The future of disease detection and monitoring.. J. Mass Spectrom. 2024;59:e5083.
    doi: 10.1002/jms.5083pubmed: 39162140google scholar: lookup
  4. Schjoldager K.T., Narimatsu Y, Joshi H.J., Clausen H. Global view of human protein glycosylation pathways and functions.. Nat. Rev. Mol. Cell Biol. 2020;21:729–749.
    doi: 10.1038/s41580-020-00294-xpubmed: 33087899google scholar: lookup
  5. Kissel T, Toes R.E.M., Huizinga T.W.J., Wuhrer M. Glycobiology of rheumatic diseases.. Nat. Rev. Rheumatol. 2023;19:28–43.
    doi: 10.1038/s41584-022-00867-4pmc: PMC9684870pubmed: 36418483google scholar: lookup
  6. Szabo E, Farago A, Bodor G, Gemes N, Puskas L.G., Kovacs L, Szebeni G.J.. Identification of immune subsets with distinct lectin binding signatures using multi-parameter flow cytometry: Correlations with disease activity in systemic lupus erythematosus.. Front. Immunol. 2024;15:1380481.
    doi: 10.3389/fimmu.2024.1380481pmc: PMC11106380pubmed: 38774868google scholar: lookup
  7. Sahin F, Kaya Z.Z., Serteser M, Ozturk H.U., Baykal A.T. Glycan profiling of multiple sclerosis oligoclonal bands with MALDI-TOF.. Anal. Methods. 2025;17:850–858.
    doi: 10.1039/D4AY01639Dpubmed: 39744984google scholar: lookup
  8. Huang J, Wang X, Li N, Fan W, Li X, Zhou Q, Liu J, Li W, Zhang Z, Liu X. YY1 Lactylation Aggravates Autoimmune Uveitis by Enhancing Microglial Functions via Inflammatory Genes.. Adv. Sci. 2024;11:e2308031.
    doi: 10.1002/advs.202308031pmc: PMC11109619pubmed: 38493498google scholar: lookup
  9. Wiedemann C, Amann B, Degroote R.L., Witte T, Deeg C.A. Aberrant Migratory Behavior of Immune Cells in Recurrent Autoimmune Uveitis in Horses.. Front. Cell Dev. Biol. 2020;8:101.
    doi: 10.3389/fcell.2020.00101pmc: PMC7076317pubmed: 32211402google scholar: lookup
  10. Peng X, Li H, Zhu L, Zhao S, Li Z, Li S, Wu D, Chen J, Zheng S, Su W. Single-cell sequencing of the retina shows that LDHA regulates pathogenesis of autoimmune uveitis.. J. Autoimmun. 2024;143:103160.
    doi: 10.1016/j.jaut.2023.103160pubmed: 38160538google scholar: lookup
  11. Deeg C.A., Hauck S.M., Amann B, Pompetzki D, Altmann F, Raith A, Schmalzl T, Stangassinger M, Ueffing M. Equine recurrent uveitis--a spontaneous horse model of uveitis.. Ophthalmic Res. 2008;40:151–153.
    doi: 10.1159/000119867pubmed: 18421230google scholar: lookup
  12. Gilger B.C.. Immune Relevant Models for Ocular Inflammatory Diseases.. ILAR J. 2018;59:352–362.
    doi: 10.1093/ilar/ily002pubmed: 29474707google scholar: lookup
  13. Soth R, Hoffmann A.L.C., Deeg C.A. Enhanced ROS Production and Mitochondrial Metabolic Shifts in CD4(+) T Cells of an Autoimmune Uveitis Model.. Int. J. Mol. Sci. 2024;25:11513.
    doi: 10.3390/ijms252111513pmc: PMC11545935pubmed: 39519064google scholar: lookup
  14. Malalana F, Stylianides A, McGowan C. Equine recurrent uveitis: Human and equine perspectives.. Vet. J. 2015;206:22–29.
    doi: 10.1016/j.tvjl.2015.06.017pubmed: 26188862google scholar: lookup
  15. Gerding J.C., Gilger B.C.. Prognosis and impact of equine recurrent uveitis.. Equine Vet. J. 2016;48:290–298.
    doi: 10.1111/evj.12451pubmed: 25891653google scholar: lookup
  16. Li Z, Liu X, Li Z, Xiao Z, Chen G, Li Y, Huang J, Hu Y, Huang H, Zhu W. STING Deficiency Promotes Th17-Like Tfh to Aggravate the Experimental Autoimmune Uveitis. Investig. Ophthalmol. Vis. Sci. 2025;66:8.
    doi: 10.1167/iovs.66.3.8pmc: PMC11892529pubmed: 40042874google scholar: lookup
  17. Barfusser C, Wiedemann C, Hoffmann ALC, Hirmer S, Deeg CA. Altered Metabolic Phenotype of Immune Cells in a Spontaneous Autoimmune Uveitis Model. Front. Immunol. 2021;12:601619.
    doi: 10.3389/fimmu.2021.601619pmc: PMC8353246pubmed: 34385998google scholar: lookup
  18. Caspi RR, Chan CC, Fujino Y, Najafian F, Grover S, Hansen CT, Wilder RL. Recruitment of antigen-nonspecific cells plays a pivotal role in the pathogenesis of a T cell-mediated organ-specific autoimmune disease, experimental autoimmune uveoretinitis. J. Neuroimmunol. 1993;47:177–188.
    doi: 10.1016/0165-5728(93)90028-Wpubmed: 8370769google scholar: lookup
  19. Kerr EC, Copland DA, Dick AD, Nicholson LB. The dynamics of leukocyte infiltration in experimental autoimmune uveoretinitis. Prog. Retin. Eye Res. 2008;27:527–535.
  20. Kerr EC, Raveney BJ, Copland DA, Dick AD, Nicholson LB. Analysis of retinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations. J. Autoimmun. 2008;31:354–361.
    doi: 10.1016/j.jaut.2008.08.006pubmed: 18838247google scholar: lookup
  21. Deeg CA, Kaspers B, Gerhards H, Thurau SR, Wollanke B, Wildner G. Immune responses to retinal autoantigens and peptides in equine recurrent uveitis. Investig. Ophthalmol. Vis. Sci. 2001;42:393–398.
    pubmed: 11157872
  22. Weigand M, Hauck SM, Deeg CA, Degroote RL. Deviant proteome profile of equine granulocytes associates to latent activation status in organ specific autoimmune disease. J. Proteom. 2021;230:103989.
    doi: 10.1016/j.jprot.2020.103989pubmed: 32977044google scholar: lookup
  23. Reno F, Pagano CA, Bignotto M, Sabbatini M. Neutrophil Heterogeneity in Wound Healing. Biomedicines 2025;13:694.
  24. Sheahan BJ, Schubert AG, Schubert W, Sheats MK, Schnabel LV, Gilbertie JM. Equine neutrophils selectively release neutrophil extracellular traps in response to chemical and bacterial agonists. Front. Vet. Sci. 2025;12:1512343.
    doi: 10.3389/fvets.2025.1512343pmc: PMC11891193pubmed: 40066197google scholar: lookup
  25. Fingerhut L, Ohnesorge B, von Borstel M, Schumski A, Strutzberg-Minder K, Morgelin M, Deeg CA, Haagsman HP, Beineke A, von Kockritz-Blickwede M. Neutrophil Extracellular Traps in the Pathogenesis of Equine Recurrent Uveitis (ERU). Cells 2019;8:1528.
    doi: 10.3390/cells8121528pmc: PMC6953072pubmed: 31783639google scholar: lookup
  26. Maier-Begandt D, Alonso-Gonzalez N, Klotz L, Erpenbeck L, Jablonska J, Immler R, Hasenberg A, Mueller TT, Herrero-Cervera A, Aranda-Pardos I. Neutrophils-biology and diversity. Nephrol. Dial. Transplant. 2024;39:1551–1564.
    doi: 10.1093/ndt/gfad266pmc: PMC11427074pubmed: 38115607google scholar: lookup
  27. Gilger BC, Michau TM. Equine recurrent uveitis: New methods of management. Vet. Clin. N. Am. Equine Pract. 2004;20:417–427.
    doi: 10.1016/j.cveq.2004.04.010pubmed: 15271431google scholar: lookup
  28. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods. 2012;9:671–675.
    doi: 10.1038/nmeth.2089pmc: PMC5554542pubmed: 22930834google scholar: lookup
  29. Kang DH, Gho YS, Suh MK, Kang CH. Highly sensitive and fast protein detection with coomassie brilliant blue in sodium dodecyl sulfate-polyacrylamide gel electrophoresis. B Korean Chem. Soc. 2002;23:1511–1512.
  30. Perez-Riverol Y, Csordas A, Bai J, Bernal-Llinares M, Hewapathirana S, Kundu DJ, Inuganti A, Griss J, Mayer G, Eisenacher M. The PRIDE database and related tools and resources in 2019: Improving support for quantification data. Nucleic Acids Res. 2019;47:D442–D450.
    doi: 10.1093/nar/gky1106pmc: PMC6323896pubmed: 30395289google scholar: lookup
  31. Steentoft C, Vakhrushev SY, Joshi HJ, Kong Y, Vester-Christensen MB, Schjoldager KT, Lavrsen K, Dabelsteen S, Pedersen NB, Marcos-Silva L. Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology. EMBO J. 2013;32:1478–1488.
    doi: 10.1038/emboj.2013.79pmc: PMC3655468pubmed: 23584533google scholar: lookup
  32. Bojar D, Meche L, Meng G, Eng W, Smith DF, Cummings RD, Mahal LK. A Useful Guide to Lectin Binding: Machine-Learning Directed Annotation of 57 Unique Lectin Specificities. ACS Chem. Biol. 2022;17:2993–3012.
    doi: 10.1021/acschembio.1c00689pmc: PMC9679999pubmed: 35084820google scholar: lookup
  33. Tachibana K, Nakamura S, Wang H, Iwasaki H, Tachibana K, Maebara K, Cheng L, Hirabayashi J, Narimatsu H. Elucidation of binding specificity of Jacalin toward O-glycosylated peptides: Quantitative analysis by frontal affinity chromatography. Glycobiology 2006;16:46–53.
    doi: 10.1093/glycob/cwj038pubmed: 16177266google scholar: lookup
  34. Lescar J, Loris R, Mitchell E, Gautier C, Chazalet V, Cox V, Wyns L, Pérez S, Breton C, Imberty A. Isolectins I-A and I-B of Griffonia(Bandeiraea) simplicifolia: Crystal structure of metal-free GS I-B4 and molecular basis for metal binding and monosaccharide specificity. J. Biol. Chem. 2002;277:6608–6614.
    doi: 10.1074/jbc.M109867200pubmed: 11714720google scholar: lookup
  35. Singh SS, Devi SK, Ng TB. Banana lectin: A brief review. Molecules 2014;19:18817–18827.
    doi: 10.3390/molecules191118817pmc: PMC6272006pubmed: 25407720google scholar: lookup
  36. Monsigny M, Sene C, Obrenovitch A, Roche AC, Delmotte F, Boschetti E. Properties of succinylated wheat-germ agglutinin. Eur. J. Biochem. 1979;98:39–45.
  37. van Kooyk Y, Rabinovich GA. Protein-glycan interactions in the control of innate and adaptive immune responses. Nat. Immunol. 2008;9:593–601.
    doi: 10.1038/ni.f.203pubmed: 18490910google scholar: lookup
  38. Wolfert MA, Boons GJ. Adaptive immune activation: Glycosylation does matter. Nat. Chem. Biol. 2013;9:776–784.
    doi: 10.1038/nchembio.1403pmc: PMC3966069pubmed: 24231619google scholar: lookup
  39. Ohnishi T, Muroi M, Tanamoto K. MD-2 is necessary for the toll-like receptor 4 protein to undergo glycosylation essential for its translocation to the cell surface. Clin. Diagn. Lab. Immunol. 2003;10:405–410.
  40. da Silva Correia J, Ulevitch RJ. MD-2 and TLR4 N-linked glycosylations are important for a functional lipopolysaccharide receptor. J. Biol. Chem. 2002;277:1845–1854.
    doi: 10.1074/jbc.M109910200pubmed: 11706042google scholar: lookup
  41. Kawahara R, Ugonotti J, Chatterjee S, Tjondro HC, Loke I, Parker BL, Venkatakrishnan V, Dieckmann R, Sumer-Bayraktar Z, Karlsson-Bengtsson A. Glycoproteome remodeling and organelle-specific N-glycosylation accompany neutrophil granulopoiesis. Proc. Natl. Acad. Sci. USA. 2023;120:e2303867120.
    doi: 10.1073/pnas.2303867120pmc: PMC10483621pubmed: 37639587google scholar: lookup
  42. Hoffmann ALC, Hauck SM, Deeg CA, Degroote RL. Pre-Activated Granulocytes from an Autoimmune Uveitis Model Show Divergent Pathway Activation Profiles upon IL8 Stimulation In Vitro. Int. J. Mol. Sci. 2022;23:9555.
    doi: 10.3390/ijms23179555pmc: PMC9455241pubmed: 36076947google scholar: lookup
  43. Ugonotti J, Chatterjee S, Thaysen-Andersen M. Structural and functional diversity of neutrophil glycosylation in innate immunity and related disorders. Mol. Asp. Med. 2021;79:100882.
    doi: 10.1016/j.mam.2020.100882pubmed: 32847678google scholar: lookup
  44. Hughes V, Humphreys JM, Edwards SW. Protein synthesis is activated in primed neutrophils: A possible role in inflammation. Biosci. Rep. 1987;7:881–890.
    doi: 10.1007/BF01119479pubmed: 2452660google scholar: lookup
  45. McMullen RJ Jr, Fischer BM. Medical and Surgical Management of Equine Recurrent Uveitis. Vet. Clin. N. Am. Equine Pract. 2017;33:465–481.
    doi: 10.1016/j.cveq.2017.07.003pubmed: 28985983google scholar: lookup
  46. Gilger BC, Malok E, Cutter KV, Stewart T, Horohov DW, Allen JB. Characterization of T-lymphocytes in the anterior uvea of eyes with chronic equine recurrent uveitis. Vet. Immunol. Immunopathol. 1999;71:17–28.
    doi: 10.1016/S0165-2427(99)00082-3pubmed: 10522783google scholar: lookup
  47. Deeg CA, Ehrenhofer M, Thurau SR, Reese S, Wildner G, Kaspers B. Immunopathology of recurrent uveitis in spontaneously diseased horses. Exp. Eye Res. 2002;75:127–133.
    doi: 10.1006/exer.2002.2011pubmed: 12137758google scholar: lookup
  48. Deeg CA, Thurau SR, Gerhards H, Ehrenhofer M, Wildner G, Kaspers B. Uveitis in horses induced by interphotoreceptor retinoid-binding protein is similar to the spontaneous disease. Eur. J. Immunol. 2002;32:2598–2606.
  49. Degroote RL, Schmalen A, Hauck SM, Deeg CA. Unveiling Differential Responses of Granulocytes to Distinct Immunostimulants with Implications in Autoimmune Uveitis. Biomedicines 2023;12:19.
  50. Fingerhut L, Yucel L, Strutzberg-Minder K, von Kockritz-Blickwede M, Ohnesorge B, de Buhr N. Ex Vivo and In Vitro Analysis Identify a Detrimental Impact of Neutrophil Extracellular Traps on Eye Structures in Equine Recurrent Uveitis. Front. Immunol. 2022;13:830871.
    doi: 10.3389/fimmu.2022.830871pmc: PMC8896353pubmed: 35251020google scholar: lookup
  51. Horohov DW. The equine immune responses to infectious and allergic disease: A model for humans?. Mol. Immunol. 2015;66:89–96.
    doi: 10.1016/j.molimm.2014.09.020pubmed: 25457878google scholar: lookup
  52. Deeg CA, Raith AJ, Amann B, Crabb JW, Thurau SR, Hauck SM, Ueffing M, Wildner G, Stangassinger M. CRALBP is a highly prevalent autoantigen for human autoimmune uveitis. Clin. Dev. Immunol. 2007;2007:39245.
    doi: 10.1155/2007/39245pmc: PMC2246040pubmed: 18317528google scholar: lookup
  53. Zschaler J, Schlorke D, Arnhold J. Differences in innate immune response between man and mouse. Crit. Rev. Immunol. 2014;34:433–454.
  54. Li Z, Li Z, Hu Y, Xie Y, Shi Y, Chen G, Huang J, Xiao Z, Zhu W, Huang H. Neutrophil extracellular traps potentiate effector T cells via endothelial senescence in uveitis. JCI Insight. 2025;10:e180248.
    doi: 10.1172/jci.insight.180248pmc: PMC11790022pubmed: 39846254google scholar: lookup
  55. Varki A. Biological roles of glycans. Glycobiology 2017;27:3–49.
    doi: 10.1093/glycob/cww086pmc: PMC5884436pubmed: 27558841google scholar: lookup
  56. Andre S, Kaltner H, Kayser K, Murphy PV, Gabius HJ. Merging carbohydrate chemistry with lectin histochemistry to study inhibition of lectin binding by glycoclusters in the natural tissue context. Histochem. Cell Biol. 2016;145:185–199.
    doi: 10.1007/s00418-015-1383-6pubmed: 26553286google scholar: lookup
  57. Sun Y, Li X, Wang T, Li W. Core Fucosylation Regulates the Function of Pre-BCR, BCR and IgG in Humoral Immunity. Front. Immunol. 2022;13:844427.
    doi: 10.3389/fimmu.2022.844427pmc: PMC8990897pubmed: 35401499google scholar: lookup
  58. Venkatakrishnan V, Dieckmann R, Loke I, Tjondro HC, Chatterjee S, Bylund J, Thaysen-Andersen M, Karlsson NG, Karlsson-Bengtsson A. Glycan analysis of human neutrophil granules implicates a maturation-dependent glycosylation machinery. J. Biol. Chem. 2020;295:12648–12660.
    doi: 10.1074/jbc.RA120.014011pmc: PMC7476722pubmed: 32665399google scholar: lookup
  59. Lorenz L, Amann B, Hirmer S, Degroote RL, Hauck SM, Deeg CA. NEU1 is more abundant in uveitic retina with concomitant desialylation of retinal cells. Glycobiology 2021;31:873–883.
    doi: 10.1093/glycob/cwab014pubmed: 33677598google scholar: lookup
  60. Silvestre-Roig C, Fridlender ZG, Glogauer M, Scapini P. Neutrophil Diversity in Health and Disease. Trends Immunol. 2019;40:565–583.
    doi: 10.1016/j.it.2019.04.012pmc: PMC7185435pubmed: 31160207google scholar: lookup
  61. Ng LG, Ostuni R, Hidalgo A. Heterogeneity of neutrophils. Nat. Rev. Immunol. 2019;19:255–265.
    doi: 10.1038/s41577-019-0141-8pubmed: 30816340google scholar: lookup
  62. Wigerblad G, Kaplan MJ. Neutrophil extracellular traps in systemic autoimmune and autoinflammatory diseases. Nat. Rev. Immunol. 2023;23:274–288.
    doi: 10.1038/s41577-022-00787-0pmc: PMC9579530pubmed: 36257987google scholar: lookup
  63. Jeyaprakash AA, Katiyar S, Swaminathan CP, Sekar K, Surolia A, Vijayan M. Structural basis of the carbohydrate specificities of jacalin: An X-ray and modeling study. J. Mol. Biol. 2003;332:217–228.
    doi: 10.1016/S0022-2836(03)00901-Xpubmed: 12946359google scholar: lookup
  64. Rubin JR, Taylor SK, Rudchenko S, Stojanovic MN, Hess H. Single Molecule Kinetic Fingerprinting of Glycans on IgA1 Antibodies. Anal. Chem. 2025;97:14388–14396.
  65. Gurrea-Rubio M, Fox DA, Castresana JS. CD6 in Human Disease. Cells 2025;14:272.
    doi: 10.3390/cells14040272pmc: PMC11853562pubmed: 39996744google scholar: lookup
  66. Zhang L, Borjini N, Lun Y, Parab S, Asonye G, Singh R, Bell BA, Bonilha VL, Ivanov A, Fox DA. CDCP1 regulates retinal pigmented epithelial barrier integrity for the development of experimental autoimmune uveitis.. JCI Insight 2022;7:e157038.
    doi: 10.1172/jci.insight.157038pmc: PMC9675461pubmed: 35951427google scholar: lookup
  67. Wen L, Moser M, Ley K. Molecular mechanisms of leukocyte β2 integrin activation.. Blood 2022;139:3480–3492.
    doi: 10.1182/blood.2021013500pmc: PMC10082358pubmed: 35167661google scholar: lookup
  68. Brazil JC, Sumagin R, Cummings RD, Louis NA, Parkos CA. Targeting of Neutrophil Lewis X Blocks Transepithelial Migration and Increases Phagocytosis and Degranulation.. Am. J. Pathol. 2016;186:297–311.
  69. Brazil JC, Kelm M, Lehoux S, Azcutia V, Cummings RD, Nusrat A, Parkos CA. Regulation of Neutrophil Function by Selective Targeting of Glycan Epitopes Expressed on the Integrin CD11b/CD18.. FASEB J. 2020;34:1.
  70. Azcutia V, Kelm M, Fink D, Cummings RD, Nusrat A, Parkos CA, Brazil JC. Sialylation regulates neutrophil transepithelial migration, CD11b/CD18 activation, and intestinal mucosal inflammatory function.. JCI Insight 2023;8:e167151.
    doi: 10.1172/jci.insight.167151pmc: PMC10077474pubmed: 36719745google scholar: lookup

Citations

This article has been cited 0 times.